Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients
(1) Background: The purpose of this study is to compare the rate of COVID-19 vaccination among psoriasis patients internationally and to correlate it with their treatment regimens. (2) Methods: We conducted a cross-sectional study from January 2021 to October 2022 among adults in the United States (US), Chile, China, Switzerland, and Singapore using the Global Healthcare Study on Psoriasis survey. (3) Results: A total of 310 psoriasis patients in the US (98), Chile (32), China (80), Switzerland (39), and Singapore (61) were surveyed. Of these, 248 patients (80.0%) were vaccinated at least once for COVID-19 (Chile: 100%, Singapore: 100%, US: 93.9%, Switzerland: 69.2%, China: 45.0%). Compared with other countries, patients in China were 89% less likely to report at least one COVID-19 vaccination (1 - 0.11 = 0.89; OR 0.11; 95% CI: 0.03-0.48), and patients in Switzerland were 80% less likely (1 - 0.20 = 0.80; OR 0.20; 95% CI: 0.05-0.79). Compared with patients on biologics, patients on topicals were 10.9 (95% CI: 2.1-56.6) times more likely to report at least one COVID-19 vaccination, and patients on oral systemics were 7.2 times more likely (95% CI: 1.6-31.6). (4) Conclusions: Country of residence and treatment regimen are associated with different COVID-19 vaccination rates in psoriasis patients.
Authors
- Hazel H. Oon (ORCID: https://orcid.org/0000-0001-7607-3124)
- Lara Valeska Maul (ORCID: https://orcid.org/0000-0001-9202-0073)
- Alexander Egeberg (ORCID: https://orcid.org/0000-0001-8257-1816)
- Rosario Agüero (ORCID: https://orcid.org/0000-0001-5476-8494)
- April Wang Armstrong (ORCID: https://orcid.org/0000-0003-0064-8707)
- Fernando Valenzuela (ORCID: https://orcid.org/0000-0003-1032-9347)
- Margaret Y. Huang
- Hannah Peterson
- Danielle Yee (ORCID: https://orcid.org/0000-0002-0486-2033)
- Kathryn Lee (ORCID: https://orcid.org/0000-0002-0150-4513)
- Paige Kingston
- Johannes A. Didaskalu (ORCID: https://orcid.org/0000-0001-5145-3921)
- Ricardo Romiti (ORCID: https://orcid.org/0000-0003-0165-3831)
- Julia‐Tatjana Maul (ORCID: https://orcid.org/0000-0002-9914-1545)
- Edwin Korouri
- Kevin Artiga (ORCID: https://orcid.org/0009-0002-0089-959X)
- Charlotte Jeong
Institutions
- University of Southern California (US)
- University of Copenhagen (DK)
- National Skin Centre (SG)
- University of California, Los Angeles (US)
- Universidade de São Paulo (BR)
- Rosalind Franklin University of Medicine and Science (US)
- University of Zurich (CH)
- Bispebjerg Hospital (DK)
- University Hospital of Zurich (CH)
- University of Chile (CL)
- University of Arkansas for Medical Sciences (US)
- Centro de Estudios Científicos (CL)
Publication Details
- Journal
- Life
- Published
- 2024-10-13
- DOI
- https://doi.org/10.3390/life14101297
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78